Related Experiment Videos
Vitrectomy with internal limiting membrane removal for clinically significant macular oedema.
Ferenc Kuhn1, Gyöngyi Kiss, Viktória Mester
1Helen Keller Foundation for Research and Education, Birmingham, Alabama, USA. fkuhn@mindspring.com
Summary
Vitrectomy with internal limiting membrane (ILM) peeling effectively treats persistent clinically significant macular oedema (CSME). This procedure offers significant visual acuity improvement in most patients unresponsive to laser treatment.
Area of Science:
- Ophthalmology
- Retinal Surgery
- Macular Diseases
Background:
- Clinically significant macular oedema (CSME) often persists despite maximal laser treatment.
- Limited data exists on surgical interventions for refractory CSME.
Purpose of the Study:
- To evaluate the efficacy of vitrectomy with internal limiting membrane (ILM) peeling for CSME unresponsive to laser therapy.
Main Methods:
- Retrospective review of 30 eyes undergoing vitrectomy, ILM peeling, and gas tamponade.
- Single surgeon, with a mean follow-up of 12 months.
Main Results:
- 90% of eyes achieved complete oedema resolution; 80% showed visual acuity improvement.
- Significant visual gains were observed in eyes with cystoid macular oedema (CME).
- No intraoperative complications related to ILM peeling were reported.
Conclusions:
- Vitrectomy with ILM peeling is a promising surgical option for CSME refractory to laser treatment.
- This approach demonstrates higher visual improvement rates and potentially longer-lasting effects than laser or intravitreal therapies.
- Further research with larger cohorts is warranted to confirm these findings.